GlassScriptPhysician profile
Gregory Rauscher
NPI 1346244159
$3,290.08
in general payments reported to CMS, 2019-2025
11 companies · $29.10 in 2025
The $29.10 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $64.62 · 2021: $1,371 · 2022: $771 · 2023: $419 · 2024: $363 · 2025: $29.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $595 · Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $594.50 |
| Food and Beverage | $216.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,737.14 | 2021-2022 | |
| Abbvie INC. | $627.72 | 2023-2024 | |
| Smith+Nephew, INC. | $437.07 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Endo Pharmaceuticals INC. | $155.72 | 2019-2023 | Xiaflex |
| Polarityte, INC. | $139.09 | 2019-2021 | |
| Axogen | $71.80 | 2019-2021 | |
| Integra Lifesciences Corporation | $54.35 | 2019 | |
| Angiodynamics, INC. | $20.10 | 2019 | |
| Next Science LLC | $17.57 | 2023 | Blastx, Xperience, Surgx |
| Leo Pharma INC. | $14.98 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.54 | 2023 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Rauscher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.